Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125427821 | 12542782 | 1 | I | 201604 | 20160630 | 20160709 | 20160709 | PER | US-009507513-1607USA000501 | MERCK | 61.52 | YR | M | Y | 0.00000 | 20160709 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125427821 | 12542782 | 1 | PS | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | Oral | UNK | 21995 | FILM-COATED TABLET | |||||||||
| 125427821 | 12542782 | 2 | C | GLIMEPIRIDE. | GLIMEPIRIDE | 1 | U | 0 | |||||||||||
| 125427821 | 12542782 | 3 | C | FARXIGA | DAPAGLIFLOZIN PROPANEDIOL | 1 | U | 0 |
Indications of drugs used
| no results found |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125427821 | 12542782 | Blood glucose decreased | |
| 125427821 | 12542782 | Glycosylated haemoglobin increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |